A Toxicologist's Guide to the Preclinical Assessment of Hepatic Microsomal Enzyme Induction

REFERENCES

• Amacher D. E., Schomaker S. J., Burkhardt J. E. The relationship among microsomal enzyme induction, liver weight and histological change in beagle dog toxicology studies. Food Chem. Toxicol. 2001; 39: 817–825, [INFOTRIEVE], [CSA]
   Google Scholar
• Amacher D. E., Schomaker S. J., Burkhardt J. E. The relationship among microsomal enzyme induction, liver weight and histological change in rat toxicology studies. Food Chem. Toxicol. 1998a; 36: 831–839, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Amacher D. E., Schomaker S. J. Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes. Toxicol. Lett. 1998b; 94: 115–125, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Amacher D. E., Schomaker S. J., Boldt S. E., Mirsky M. The relationship among microsomal enzyme induction, liver weight, and histological change in cynomolgus monkey toxicology studies. Food Chem. Toxicol. 2006; 44: 528–537, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Badawi A. F., Cavalieri E. L., Rogan E. G. Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17beta-estradiol in female Sprague-Dawley rats. Carcinogenesis 2000; 21: 1593–1599, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Barbier O., Torra I. P., Sirvent A., Claudel T., Blanquart C., Duran-Sandoval D., Kuipers F., Kosykh V., Fruchart J. C., Staels B. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 2003a; 124: 1926–1940, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Barbier O., Villeneuve L., Bocher V., Fontaine C., Torra I. P., Duhem C., Kosykh V., Fruchart J. C., Guillemette C., Staels B. The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. J. Biol. Chem. 2003b; 278: 13975–13983, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bock K. W., Gschaidmeier H., Heel H., Lehmkoster T., Munzel P. A., Raschko F., Bock-Hennig B. AH receptor-controlled transcriptional regulation and function of rat and human UDP-glucuronosyltransferase isoforms. Adv Enzyme Regul. 1998; 38: 207–222, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Bogaards J. J., Bertrand M., Jackson P., Oudshoorn M. J., Weaver R. J., van Bladeren P. J., Walther B. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000; 30: 1131–1152, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bouwman C. A., Van Dam E., Fase K. M., Koppe J. G., Seinen W., Thijssen H. H., Vermeer C., Van den Berg M. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin or 2,2′,4,4′,5,5′-hexachlorobiphenyl on vitamin K-dependent blood coagulation in male and female WAG/Rij-rats. Chemosphere 1999; 38: 489–505, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Boll M., Weber L. W., Font M., Stampfl A. The enzyme inducers 3-methylcholanthrene and phenobarbital affect the activities of glucocorticoid hormone-regulated enzymes in rat liver and kidney. Toxicology 1998; 126: 127–136, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bookstaff R. C., Murphy V. A., Skare J. A., Minnema D., Sanzgiri U., Parkinson A. Effects of doxylamine succinate on thyroid hormone balance and enzyme induction in mice. Toxicol. Appl. Pharmacol. 1996; 141: 584–594, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Buhler R., Lindros K. O., Nordling A., Johansson I., Ingelman-Sundberg M. Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur. J. Biochem. 1992; 204: 407–412, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Chen C., Staudinger J. L., Klaassen C. D. Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab. Dispo. 2003; 31: 908–915, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chen Y. L., Florentin I., Batt A. M., Ferrari L., Giroud J. P., Chauvelot-Moachon L. Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem. Pharmacol. 1992; 44: 137–148, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Comer C. P., Chengelis C. P., Levin S., Kotsonis F. N. Changes in thyroidal function and liver UDPglucuronosyltransferase activity in rats following administration of a novel imidazole (SC-37211). Toxicol. Appl. Pharmacol. 1985; 80: 427–436, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Coulson M., Gibson G. G., Plant N., Hammond T., Graham M. Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis. Toxicol. Appl. Pharmacol. 2003; 192: 154–163, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Desta Z., Soukhova N. V., Flockhart D. A. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A. Antimicrobial Agents Chemother 2001; 45: 382–392, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Diamond S., Rakestraw D., O'Neil J., Lam G. N., Christ D. D. Induction of cytochromes P-450 2B and 3A in mice following the dietary administration of the novel cognitive enhancer linopirdine. Drug Metab. Dispo. 1994; 22: 65–73, [CSA]
   Google Scholar
• Dohler K. D., Wong C. C., von zur Muhlen A. The rat as model for the study of drug effects on thyroid function: consideration of methodological problems. Pharmacol. Ther.—Part B: Gen. Systematic Pharmacol. 1979; 5: 305–318, [CSA]
   Google Scholar
• Donato M. T., Jimenez N., Castell J. V., Gomez-Lechon M. J. Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab. Dispo. 2004; 32: 699–706, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dvorak Z., Modriansky M., Pichard-Garcia L., Balaguer P., Vilarem M. J., Ulrichova J., Maurel P., Pascussi J. M. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol. Pharmacol. 2003; 64: 160–169, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Eeckhoudt S. L., Desager J. P., Robert A. R., Leclercq I., Verbeeck R. K., Horsmans Y. Midazolam and cortisol metabolism before and after CYP3A induction in humans. Int. J. Clin. Pharmacol. Ther. 2001; 39: 293–299, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Embola C. W., Sohn O. S., Fiala E. S., Weisburger J. H. Induction of UDP-glucuronosyltransferase 1 (UDP-GT1) gene complex by green tea in male F344 rats. Food Chem. Toxicol. 2002; 40: 841–844, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Feuer G. Drug control of steroid metabolism by the hepatic endoplasmic reticulum. Drug Metab. Rev. 1983; 14: 1119–1144, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Franklin M. R. Induction of rat liver drug-metabolizing enzymes by heterocycle-containing mono-, di-, tri- and tetra-arylmethanes. Biochem. Pharmacol. 1993; 46: 683–689, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Frye R. F., Matzke G. R., Adedoyin A., Porter J. A., Branch R. A. Validation of the five-drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug-metabolizing enzymes. Clin. Pharmacol. Ther. 1997; 62: 365–376, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fujisaki H., Mise M., Ishii Y., Yamada H., Oguri K. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase. J. Pharmacol. Exp. Ther. 1994; 268: 1024–1031, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gagne D., Labhilili M., Pons M. Description and analysis of differential sensitivity to glucocorticoids in Fao cells. J. Steroid Biochem. 1988; 31: 917–925, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Gibson G. G., Plant N. J., Swales K. E., Ayrton A., El-Sankary W. Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 2002; 32: 165–206, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J. Molecular genetics of the P-450 superfamily. Pharmacol. Ther. 1990; 45: 1–38, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Groen K., Breimer D. D., Jansen E. J., van Bezooijen C. F. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study. J. Pharmacol. Exp. Ther. 1994; 268: 531–536, [INFOTRIEVE], [CSA]
   Google Scholar
• Graham R. A., Downey A., Mudra D., Krueger L., Carroll K., Chengelis C., Madan A., Parkinson A. In vivo and in vitro induction of cytochrome P450 enzymes in beagle dogs. Drug Metab. Dispo. 2002; 30: 1206–1213, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Handschin C., Meyer U. A. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch. Biochem. Biophys. 2005; 433: 387–396, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Huang L., Zhao A., Lew J. L., Zhang T., Hrywna Y., Thompson J. R., de Pedro N., Royo I., Blevins R. A, Pelaez F., Wright S. D., Cui J. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J. Biol. Chem. 2003; 278: 51085–51090, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Halpert J. R. Structural basis of selective cytochrome P450 inhibition. Annu. Rev. Pharmacol. Toxicol. 1995; 35: 29–53, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Huitema A. D., Mathot R. A., Tibben M. M., Rodenhuis S., Beijnen J. H. A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide. J. Pharmacokinet. Pharmacodyn. 2001; 28: 211–230, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ioannides C. Cytochrome P450 Metabolic and Toxicological Aspects. CRC Press, New York. 1996
   Google Scholar
• Jacobs M. N., Dickins M., Lewis D. F. Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure. J. Steroid Biochem. Mol. Biol. 2003; 84: 117–132, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jayyosi Z., Muc M., Erick J., Thomas P. E., Kelley M. Catalytic and immunochemical characterization of cytochrome P450 isozyme induction in dog liver. Fundam. Appl. Toxicol. 1996; 31: 95–102, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Jirtle R. L., Meyer S. A., Brockenbrough J. S. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. Prog. Clin. Biol. Res. 1991; 369: 209–216, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Jones S. A., Moore L. B., Shenk J. L., Wisely G. B., Hamilton G. A., McKee D. D., Tomkinson N. C., LeCluyse E. L., Lambert M. H., Willson T. M., Kliewer S. A., Moore J. T. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol. 2000; 14: 27–39, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jurima-Romet M., Crawford K., Cyr T., Inaba T. Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals. Drug Metab. Dispo. 1994; 22: 849–857, [CSA]
   PubMed Web of Science ®Google Scholar
• Kato R., Yamazoe Y. Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol. Lett. 1992; 64–65 Spec No: 661–667, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Keller N., Richardson U. I., Yates F. E. Protein binding and the biological activity of corticosteroids: in vivo induction of hepatic and pancreatic alanine aminotransferases by corticosteroids in normal and estrogen-treated rats. Endocrinology 1969; 84: 49–62, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kenyon K. W., Nappi J. M. Bosentan for the treatment of pulmonary arterial hypertension. Ann. Pharmacother. 2003; 37: 1055–1062, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kerbusch T., Jansen R. L., Mathot R. A., Huitema A. D., Jansen M., van Rijswijk R. E., Beijnen J. H. Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin. Clin. Pharmacol. Ther. 2001; 70: 132–141, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kiernan T. W., Luisada-Opper A., Ertel N. H. Hepatic microsomal induction in rat liver: heterogeneity of response. J. Clin. Pharmacol. 1981; 21: 280–283, [INFOTRIEVE], [CSA]
   Google Scholar
• Kim Y., Sills R. C., Houle C. D. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Toxicol. Pathol. 2005; 33: 175–180, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• King C. D., Rios G. R., Green M. D., Tephly T. R. UDP-glucuronosyltransferases. Curr. Drug Metab. 2000; 1: 143–161, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• King T. J., Lampe P. D. The gap junction protein connexin32 is a mouse lung tumor suppressor. Cancer Res. 2004; 64: 7191–7196, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Landes N., Birringer M., Brigelius-Flohe R. Homologous metabolic and gene activating routes for vitamins E and K. Mol. Aspects Med. 2003; 24: 337–344, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ledirac N., de Sousa G., Fontaine F., Agouridas C., Gugenheim J., Lorenzon G., Rahmani R. Effects of macrolide antibiotics on CYP3A expression in human and rat hepatocytes: interspecies differences in response to troleandomycin. Drug Metab. Dispo. 2000; 28: 1391–1393, [CSA]
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Guide to Cytochromes P450 Structure and Function. Taylor & Francis, New York. 2001
   Google Scholar
• Li D. N., Pritchard M. P., Hanlon S. P., Burchell B., Wolf C. R., Friedberg T. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism. J. Pharmacol. Exp. Ther. 1999; 289: 661–667, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lindros K. O. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen. Pharmacol. 1997; 28: 191–196, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Lubet R. A., Nims R. W., Ward J. M., Rice J. M., Diwan B. A. Induction of cytochrome P450 and its relationship to liver tumor promotion. J. Am. Coll. Toxicol. 1989; 8: 259–268, [CSA]
   Google Scholar
• Marshall W. J. Enzyme induction by drugs. Its relevance to clinical biochemistry. Ann. Clin. Biochem. 1978; 15: 55–64, [INFOTRIEVE], [CSA]
   Google Scholar
• Matzke G. R., Frye R. F., Early J. J., Straka R. J., Carson S. W. Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity. Pharmacotherapy, 20: 182–190, [CSA]
   Google Scholar
• McClain R. M. The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia. Toxicol. Pathol. 1989; 17: 294–306, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mirochnick M., Clarke D. F., Dorenbaum A. Nevirapine: pharmacokinetic considerations in children and pregnant women. Clin. Pharmacokinet. 2000; 39: 281–293, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Moennikes O., Buchmann A., Romualdi A., Ott T., Werringloer J., Willecke K., Schwarz M. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. Cancer Res. 2000; 60: 5087–5091, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Moore L. B., Parks D. J., Jones S. A., Bledsoe R. K., Consler T. G., Stimmel J. B., Goodwin B., Liddle C., Blanchard S. G., Willson T. M., Collins J. L., Kliewer S. A. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 2000; 275: 15122–15127, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Muntane-Relat J., Ourlin J. C., Domergue J., Maurel P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995; 22(4 Pt 1)1143–1153, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Muller P. B., Taboada J., Hosgood G., Partington B. P., VanSteenhouse J. L., Taylor H. W., Wolfsheimer K. J. Effects of long-term phenobarbital treatment on the liver in dogs. J. Vet. Intern. Med. 2000; 14: 165–171, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Murray M, Reidy G. F. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 1990; 42: 85–101, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Adesnik M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B., Levin W., Phillips I. R., Sato R., Waterman M. R. The P450 gene superfamily: recommended nomenclature. DNA. 1987; 6: 1–11, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R, Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1–42, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O., Okuda K., Nebert D. W. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993; 12: 1–51, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Neveu M. J., Babcock K. L., Hertzberg E. L., Paul D. L., Nicholson B. J., Pitot H. C. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res. 1994; 54: 3145–3152, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nishibe Y., Wakabayashi M., Harauchi T., Ohno K. Characterization of cytochrome P450 (CYP3A12) induction by rifampicin in dog liver. Xenobiotica 1998; 28: 549–557, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• O'Brien P. J., Slaughter M. R., Polley S. R., Kramer K. Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. Lab. Anim. 2002; 36: 313–321, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Okey A. B. Enzyme induction in the cytochrome P-450 system. Pharmacol. Ther. 1990; 45: 241–298, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Oinonen T., Saarikoski S., Husgafvel-Pursiainen K., Hirvonen A., Lindros K. O. Pretranslational induction of cytochrome P4501A enzymes by beta-naphthoflavone and 3-methylcholanthrene occurs in different liver zones. Biochem. Pharmacol. 1994; 48: 2189–2197, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R., Mico B. A., Mathews J. M., Kunze K. L., Miwa G. T., Lu A. Y. Selective inactivation of cytochrome P-450 isozymes by suicide substrates. Arch. Biochem. Biophys. 1981; 210: 717–728, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Palmer C. N., Coate P. J., Davies S. E., Shephard E. A., Phillips I. R. Localization of cytochrome P-450 gene expression in normal and diseased human liver by in situ hybridization of wax-embedded archival material. Hepatology 1992; 16: 682–687, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pascussi J. M., Gerbal-Chaloin S., Drocourt L., Maurel P., Vilarem M. J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim. Biophys. Acta. 2003; 1619: 243–253, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab. Rev. 2002; 34: 83–448, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Renwick A. B., Lavignette G., Worboy P. D., Williams B., Surry D., Lewis D. F., Price R. J., Lake B. G., Evans D. C. Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes. Xenobiotica 2001; 31: 861–878, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ritter J. K., Franklin M. R. Induction and inhibition of rat hepatic drug metabolism by N-substituted imidazole drugs. Drug Metab. Dispo. 1987; 15: 335–343, [CSA]
   PubMed Web of Science ®Google Scholar
• Robertson D. G., Krause B. R., Welty D. F., Wolfgang G. H., Graziano M. J., Pilcher G. D., Urda E. Hepatic microsomal induction profile of carbamic acid [[2,6-bis(1- methylethyl)phenoxy] sulfonyl]-2,6-bis(1-methylethyl) phenyl ester, monosodium salt (PD138142–15), a novel lipid regulating agent. Biochem. Pharmacol. 1995; 49: 799–808, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Rodrigues A. D., Wong S. L. Application of human liver microsomes in metabolism-based drug-drug interactions: in vitro-in vivo correlations and the Abbott Laboratories experience. Adv. Pharmacol. 1997; 43: 65–101, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Roffey S. J., Cole S., Comby P., Gibson D., Jezequel S. G., Nedderman A. N., Smith D. A., Walker D. K., Wood N. The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. Drug Metab. Dispo. 2003; 31: 731–741, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rosalki S. B. Plasma enzyme changes and their interpretation in patients receiving anticonvulsant and enzyme induction drugs. Anticonvulsant Drugs and Enzyme Induction, A. Richens, F. P. Woodford. Elsevier, Amsterdam 1976; 27
   Google Scholar
• Rosenbrock H., Hagemeyer C. E., Singec I., Knoth R., Volk B. Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms. J. Neuroendocrinol. 1999; 11: 597–604, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Runge D. M., Stock T. W., Lehmann T., Taege C., Bernauer U., Stolz D. B., Hofmann S., Foth H. Expression of cytochrome P450 2E1 in normal human bronchial epithelial cells and activation by ethanol in culture. Arch. Toxicol. 2001; 75: 335–345, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Salphati L., Benet L. Z. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers. Biochem. Pharmacol. 1998; 55: 387–395, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sanders J. E., Eigenberg D. A., Bracht L. J., Wang W. R., van Zwieten M. J. Thyroid and liver trophic changes in rats secondary to liver microsomal enzyme induction caused by an experimental leukotriene antagonist (L-649,923). Toxicol. Appl. Pharmacol. 1988; 95: 378–387, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Schomaker S. J., Boldt S. E., Amacher D. E. The effects of five human microsomal enzyme inhibitors on the cytochrome P450 system of the CD rat liver. (abstract). Drug Metab. Rev. 2004; 36: 276, [CSA]
   Google Scholar
• Schomaker S. J., Amacher D. E. HPLC Analysis of Progesterone Metabolism Catalyzed by Rat Hepatic P450 Isozymes. (Abstract). Proceedings, International Society for the Study of Xenobiotics. North American Meeting, Nashville, TN 1999; Vol 15 9th
   Google Scholar
• Schuetz E. G. Induction of cytochromes P450. Curr. Drug Metab 2001; 2: 139–147, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schuetz E. G., Schmid W., Schutz G., Brimer C., Yasuda K., Kamataki T., Bornheim L., Myles K., Cole T. J. The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liver. Drug Metab. Dispo. 2000; 28: 268–278, [CSA]
   PubMed Web of Science ®Google Scholar
• Schwarz M., Wanke I., Wulbrand U., Moennikes O., Buchmann A. Role of connexin32 and beta-catenin in tumor promotion in mouse liver. Toxicol. Pathol. 2003; 31: 99–102, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Semler D. E., Chengelis C. P., Radzialowski F. M. The effects of chronic ingestion of spironolactone on serum thyrotropin and thyroid hormones in the male rat. Toxicol. Appl. Pharmacol. 1989; 98: 263–268, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Shen A. L., Kasper C. B. Protein and gene structure and regulation of NADPH-cytochrome P450 oxidoreductase. Cytochrome P-450, J. B. Shenkman, H. Griem. Springer-Verlag, Berlin 1993; Vols. 35–59
   Google Scholar
• Sharer J. E., Shipley L. A., Vandenbranden M. R., Binkley S. N., Wrighton S. A. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and Cynomolgus monkey. Drug Metab. Dispo. 1995; 23: 1231–1241, [CSA]
   PubMed Web of Science ®Google Scholar
• Shimada T., Mimura M., Inoue K., Nakamura S., Oda H., Ohmori S., Yamazaki H. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Arch. Toxicol. 1997; 71: 401–408, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shoda T., Mitsumori K., Onodera H., Toyoda K., Uneyama C., Takada K., Hirose M. Liver tumor-promoting effect of beta-naphthoflavone, a strong CYP 1A1/2 inducer, and the relationship between CYP 1A1/2 induction and Cx32 decrease in its hepatocarcinogenesis in the rat. Toxicol. Pathol. 2000; 28: 540–547, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Shoda T., Mitsumori K., Onodera H., Toyoda K., Uneyama C., Imazawa T., Hirose M. The relationship between decrease in Cx32 and induction of P450 isozymes in the early phase of clofibrate hepatocarcinogenesis in the rat. Arch. Toxicol. 1999; 73: 373–380, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Simonsson U. S., Jansson B., Hai T. N., Huong D. X., Tybring G., Ashton M. Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Clin. Pharmacol. Ther. 2003; 74: 32–43, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sladek R., Giguere V. Orphan nuclear receptors: an emerging family of metabolic regulators. Adv. Pharmacol. 2000; 47: 23–87, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Sonderfan A. J., Arlotto M. P., Dutton D. R., McMillen S. K., Parkinson A. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 1987; 255: 27–41, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sohn H. O., Lim H. B., Lee Y. G., Lee D. W., Lee K. B. Modulation of cytochrome P-450 induction by long-term food restriction in male rats. Biochem. Mol. Biol. Int. 1994; 32: 889–896, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Stevens J. C., Shipley L. A., Cashman J. R., Vandenbranden M., Wrighton S. A. Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. Drug Metab. Dispo. 1993; 21: 753–760, [CSA]
   PubMed Web of Science ®Google Scholar
• Strolin Benedetti M., Dostert P. Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies. Environ. Health Perspect. 1994; 102(Suppl 9)101–105, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sugatani J., Nishitani S., Yamakawa K., Yoshinari K., Sueyoshi T., Negishi M., Miwa M. Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol. Pharmacol. 2005; 67: 845–855, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Swinney D. C., Ryan D. E., Thomas P. E., Levin W. Regioselective progesterone hydroxylation catalyzed by eleven rat hepatic cytochrome P-450 isozymes. Biochemistry 1987; 26: 7073–7083, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Takikawa H. Hepatobiliary transport of bile acids and organic anions. J. Hepato-Biliary-Pancreat. Surg 2002; 9: 443–447, [CSA]
   PubMedGoogle Scholar
• Testa B., Jenner P. Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metab. Rev. 1981; 12: 1–117, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Totis M., Magdalou J., Fournel-Gigleux S., Batt A. M., Siest G. Induction of UDP-glucuronosyltransferase isozymes in male and female rat liver microsomes by an isoquinoleine derivative (52028 RP). Biochem. Pharmacol. 1989; 38: 3634–3638, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Tucker G. T., Houston J. B., Huang S. M. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential—towards a consensus. Br. J. Clin. Pharmacol. 2001; 52: 107–117, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ueda A., Hamadeh H. K., Webb H. K., Yamamoto Y., Sueyoshi T., Afshari C. A., Lehmann J. M., Negishi M. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol. 2002; 61: 1–6, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• van der Hoeven T. Testosterone oxidation by rat liver microsomes: effects of phenobarbital pretreatment and the detection of seven metabolites by HPLC. Biochem. Biophys. Res. Commun. 1981; 100: 1285–1291, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Waechter F., Beilstein P., Burger A. G., O'Connell M., Fabreguettes C., Forster R., Weideli H. Subchronic toxicity study with ethylene-bis-(oxyethylene)-bis-(3-tert-butyl-4-hydroxy-5-methylhydro cin namate) in the cynomolgus monkey: lack of stimulation of the pituitary-thyroid-liver axis. Toxicol. Sci. 1999; 51: 36–43, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Wang H., LeCluyse E. L. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clin. Pharmacokinet. 2003; 42: 1331–1357, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Watkins J. B., Klaassen C. D. Induction of UDP-glucuronosyltransferase activities in Gunn, heterozygous, and Wistar rat livers by pregnenolone-16 alpha-carbonitrile. Drug Metab. Dispo. 1982; 10: 590–594, [CSA]
   PubMed Web of Science ®Google Scholar
• Wensing G., Neumann U., Ohnhaus E. E., Heidemann H. T. Effect of antipyrine and phenobarbital on renal gamma-glutamyltransferase excretion in human urine. Clin. Pharmacol. Ther. 1990; 48: 575–581, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wilson A. C., Park B. K. The effect of phenobarbitone pre-treatment on vitamin K1 disposition in the rat and rabbit. Biochem. Pharmacol. 1984; 33: 141–146, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Wong B. K., Fei P., Kong A. N. Differential induction of UDP-glucuronosyltransferase activity and gene expression in rat liver. Pharm. Res. 1995; 12: 1105–1108, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Yoo J. S., Ning S. M., Pantuck C. B., Pantuck E. J., Yang C. S. Regulation of hepatic microsomal cytochrome P450IIE1 level by dietary lipids and carbohydrates in rats. J. Nutr. 1991; 121: 959–965, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yuan R., Parmelee T., Balian J. D., Uppoor R. S., Ajayi F., Burnett A., Lesko L. J., Marroum P. In vitro metabolic interaction studies: experience of the Food and Drug Administration. Clin. Pharmacol. Ther. 1999; 66: 9–15, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yamamoto Y., Moore R., Goldsworthy T. L., Negishi M., Maronpot R. R. The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 2004; 64: 7197–7200, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zbinden G. Assessment of hyperplastic and neoplastic lesions of the thyroid gland. TIPS 1987; 8: 511–514, [CSA]
   Google Scholar
• Zhukov A., Ingelman-Sundberg M. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase. Biochem. J 1999; 340(Pt 2)453–458, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar